Oncotarget Fights Cancer Through Weekly Publications
The world is succumbing to cancer, a dangerous disease that has affected many families. To fight this disease, researchers have come together to initiate programs and meetings that can assist masses. Aside from that, they have attracted donors that can assist in finding cancer therapies. Coupled with a strong platform of technology, it has become possible to establish viable means to fight cancer. One journal that has also assisted in this battle is the famous Oncotarget.
Oncotarget is defined as a scientific journal that publishes scientific works that generate from the medical field. For researchers, this journal has been a reference point in terms of finding out what the causative agents of a disease are. That is why since its establishment, the journal has been helpful to researchers, in many ways. To break it down, Oncotarget features articles based on what a researchers have established. It all narrows down to finding workable treatments. With cancer being a life threatening disease that has affected most families, Oncotarget has been useful in disseminating critical information regarding available, modern treatment methods.
In an article published concerning e-cigars, it was established that the use of electronic cigars is not safe as the presumptions. E-cigars come with significant side effects that affects the gums. This is a deteriorating effect to a human’s health. In that case, just like normal cigarettes, e-cigars should be avoided. Oncotarget has been useful in disseminating such viable data. Well, the reliability of the journal is also something that has kept the medical field glued to the published articles. When discussing reliability, the team in charge of editing Oncotarget is an experienced team. For starters, there is Mikhail Blagosklonny,a prominent research scientist. Mikhail has an extensive background of research and oncology.
With Mikhail in charge of editorial works, Oncotarget cab be relied on in terms of content. This is because the man in charge understands the challenges that come with research and the importance of distributing viable medical data. Oncotarget is always accessible and can be printed when there is demand. That is also an advantage to the society.